Navigation Links
Bend Research increases hot-melt extrusion capacity
Date:5/22/2012

Bend, OR Bend Research Inc., a leading independent drug-formulation development and manufacturing company, announced the expansion of its existing hot-melt extrusion (HME) capacity with the addition of an 18mm Leistritz twin-screw mixer/extruder.

The 18mm Leistritz twin-screw mixer/extruder complements Bend Research's existing 27mm Leistritz and 19mm Baker Perkins extruder units, enhancing the company's melt-extrusion and continuous high-shear wet-granulation capabilities. Many projects have been successfully advanced through the use of extrusion, including one product brought to market with Bend Research's HME technology.

The 18mm extruder will blend seamlessly into Bend Research's science and engineering-based work flows for amorphous dispersions. Additionally, it will complement the company's core offerings in oral solubilization, including spray-dried dispersions (SDDs) and crystal size reduction.

"As a leader in solubility enhancement and an expert in hot-melt extrusion, we work hard to continually improve and expand in ways that minimize the time, money, and active pharmaceutical ingredient required to advance these projects," explained Rod Ray, chairman and chief executive officer at Bend Research. "The addition of this equipment enables us to use less API during formulation and process development, as well as allows for more facile transfer and scale-up from development through clinical trial manufacturing in our cGMP manufacturing facility."


'/>"/>
Contact: Phoenix Ivers
phoenix.ivers@bendresearch.com
541-382-4100
Bend Research Inc.
Source:Eurekalert

Page: 1

Related medicine news :

1. Embedded Mobile & M2M Device revenues to Rise to Almost $19 Billion Globally by 2014, Says Juniper Research
2. 2010 HSR Impact Award recognizes surgical safety research
3. MSU launches first anti-counterfeiting research program
4. Researchers map all the fragile sites of the yeast Saccharomyces cerevisiaes genome
5. UH Case Medical Center researchers publish promising findings for advanced cervical cancer
6. Researchers discover new way to kill pediatric brain tumors
7. Family Research Council: Planned Parenthood Report Oversexualizes Ten-Year-Olds, Undermines Parental Authority
8. Michael J. Fox Foundation Awards $1 Million to Drive Critical New Research Tools and Technologies in Parkinsons Drug Development
9. Luth Researchs IndicatorEDG(TM) Study Finds Americans Hopes of Achieving Their Dreams Are Fading
10. International Diabetes Federation awards $2 million to 9 global diabetes research projects
11. Gladstones Robert Mahley to receive Research!America advocacy award
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:3/22/2017)... ... March 22, 2017 , ... Sam & Associates Insurance Agency, ... and related services to residents of the region, is embarking on a charity ... and wild lands. , Endangered Species International is committed to ending the anthropogenic ...
(Date:3/22/2017)... ... March 22, 2017 , ... The American Society for ... (PA) form for prescribers to improve patients’ access to the revolutionary therapy for ... as part of the article entitled “PCSK9 Inhibitor Access Barriers: Issues and ...
(Date:3/22/2017)... ... March 22, 2017 , ... Soriant recognizes that ... bypasses that. Healthcare facilities across the country are always forced to focus ... and hospitals, across the country, an efficient and quick way to estimate savings ...
(Date:3/22/2017)... ... March 22, 2017 , ... In recognition ... print media enterprise focused on cancer patients, cancer centers and advocacy groups, and ... 12-part educational video series, “No Ifs, Ands, or Butts,” that focuses on Colorectal ...
(Date:3/22/2017)... ... March 22, 2017 , ... Influence Health, ... marketing solutions have enabled Children’s Hospital of The King’s Daughters (CHKD) to achieve ... the value of a digital marketing approach, the 206-bed pediatric teaching hospital in ...
Breaking Medicine News(10 mins):
(Date:3/22/2017)... Inc. today announced the appointment of Martyn Coombs as ... of ImaginAb, said "At ImaginAb we have exciting science and technology. ... our business, particularly in commercializing and making step changes in the ... realize our potential." ... Mr. Coombs is a recognized industry leader in nuclear medicine and ...
(Date:3/22/2017)... N.J. , March 22, 2017  CANTEL MEDICAL CORP. ... B. Hansen , President and CEO, will be presenting at ... at the Westin Grand Central Hotel in New ... April 5, 2017 at 3:00 p.m. ET. In addition, management ... A live audio webcast will be available ...
(Date:3/22/2017)... 22, 2017 Research and Markets has ... Inhibitors Market & Clinical Pipeline Insight 2022" drug pipelines ... ... Clinical Pipeline Insight 2022 report gives comprehensive insight on clinical ... immune check point inhibitors as main streamline drugs in the ...
Breaking Medicine Technology: